These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 31226474)
1. Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Barenji RV; Akdag Y; Yet B; Oner L Int J Pharm; 2019 Aug; 567():118445. PubMed ID: 31226474 [TBL] [Abstract][Full Text] [Related]
2. Application of Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing-a Review. Nagy B; Galata DL; Farkas A; Nagy ZK AAPS J; 2022 Jun; 24(4):74. PubMed ID: 35697951 [TBL] [Abstract][Full Text] [Related]
3. Data Twin-Driven Cyber-Physical Factory for Smart Manufacturing. Jwo JS; Lee CH; Lin CS Sensors (Basel); 2022 Apr; 22(8):. PubMed ID: 35458806 [TBL] [Abstract][Full Text] [Related]
4. An integrated data management and informatics framework for continuous drug product manufacturing processes: A case study on two pilot plants. Chen Y; Sampat C; Huang YS; Ganesh S; Singh R; Ramachandran R; Reklaitis GV; Ierapetritou M Int J Pharm; 2023 Jul; 642():123086. PubMed ID: 37257793 [TBL] [Abstract][Full Text] [Related]
5. Knowledge management in secondary pharmaceutical manufacturing by mining of data historians-A proof-of-concept study. Meneghetti N; Facco P; Bezzo F; Himawan C; Zomer S; Barolo M Int J Pharm; 2016 May; 505(1-2):394-408. PubMed ID: 27016500 [TBL] [Abstract][Full Text] [Related]
6. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals. Govender R; Abrahmsén-Alami S; Larsson A; Folestad S Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577 [TBL] [Abstract][Full Text] [Related]
7. Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access. Algorri M; Abernathy MJ; Cauchon NS; Christian TR; Lamm CF; Moore CMV J Pharm Sci; 2022 Mar; 111(3):593-607. PubMed ID: 34478754 [TBL] [Abstract][Full Text] [Related]
8. Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: a review. Tomba E; Facco P; Bezzo F; Barolo M Int J Pharm; 2013 Nov; 457(1):283-97. PubMed ID: 24016743 [TBL] [Abstract][Full Text] [Related]
9. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium. Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351 [TBL] [Abstract][Full Text] [Related]
10. Enabling Smart Manufacturing Research and Development using a Product Lifecycle Test Bed. Helu M; Hedberg T Procedia Manuf; 2015; 1():86-97. PubMed ID: 28664167 [TBL] [Abstract][Full Text] [Related]
11. A review on the modernization of pharmaceutical development and manufacturing - Trends, perspectives, and the role of mathematical modeling. Destro F; Barolo M Int J Pharm; 2022 May; 620():121715. PubMed ID: 35367580 [TBL] [Abstract][Full Text] [Related]
12. A Review and Qualitative Meta-Analysis of Digital Human Modeling and Cyber-Physical-Systems in Ergonomics 4.0. Paul G; Abele ND; Kluth K IISE Trans Occup Ergon Hum Factors; 2021; 9(3-4):111-123. PubMed ID: 34380380 [TBL] [Abstract][Full Text] [Related]
14. [Methodology and application of process analytical technology (PAT) for traditional Chinese medicine manufacturing:a review]. Xiong HS; Zhang Q; Zhang SN; Cai JY; Su J; Zhu YH; Yan KJ Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):22-29. PubMed ID: 36725254 [TBL] [Abstract][Full Text] [Related]
15. Spectrophotometry and pharmaceutical PAT/RTRT: Practical challenges and regulatory landscape from development to product lifecycle. Panzitta M; Calamassi N; Sabatini C; Grassi M; Spagnoli C; Vizzini V; Ricchiuto E; Venturini A; Brogi A; Brassier Font J; Pontello L; Bruno G; Minghetti P; Ricci M Int J Pharm; 2021 May; 601():120551. PubMed ID: 33831483 [TBL] [Abstract][Full Text] [Related]
16. Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT). de Matas M; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; Oostra W; Weimer M; Öhrngren P; Rantanen J Eur J Pharm Sci; 2016 Jul; 90():2-7. PubMed ID: 27112991 [TBL] [Abstract][Full Text] [Related]
17. Towards Pharma 4.0 in clinical trials: A future-orientated perspective. Hariry RE; Barenji RV; Paradkar A Drug Discov Today; 2022 Jan; 27(1):315-325. PubMed ID: 34537331 [TBL] [Abstract][Full Text] [Related]
18. Process analytical technologies and injectable drug products: Is there a future? Henriques J; Sousa J; Veiga F; Cardoso C; Vitorino C Int J Pharm; 2019 Jan; 554():21-35. PubMed ID: 30389475 [TBL] [Abstract][Full Text] [Related]
19. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650 [TBL] [Abstract][Full Text] [Related]
20. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement. Scott B; Wilcock A PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]